Maryland bills · 2026 Regular Session
Maryland SB 435
Public Health - Medetomidine and Xylazine Consumer Protection Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Folden (Republican)
Summary
No official summary is available for this bill.
Latest action(Apr 13, 2026): Motion Laid Over (Senator Ready) Adopted
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 13, 2026 · Senate
Motion Laid Over (Senator Ready) Adopted - Apr 13, 2026 · Senate
Favorable with Amendments { - Apr 13, 2026 · Senate
Favorable with Amendments Report by Finance - Feb 3, 2026 · Senate
Hearing 2/11 at 2:00 p.m. - Jan 30, 2026 · Senate
First Reading Finance